Clin2
NCT07304791Likely a fitRecruiting

Testing beam-103 safety in healthy volunteers

Healthy SubjectsHealthy Participant Study

This trial tests a new drug called BEAM-103 in healthy people to see if it's safe and how the body processes it. It's a single-blind study, meaning you won't know if you get the drug or a placebo.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
30 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • Your body mass index (BMI) is between 18.5 and 25.
  • Your white blood cell count (neutrophils) is within a certain range that varies by race.
  • Your hemoglobin levels are at least 14 for men or 12 for women.
  • Your platelet count is above 150.
  • You are in general good health with no major medical problems.
  • You have no known allergies to the study drug.
  • You haven't taken part in another drug trial in the last 90 days.
  • Women must not be pregnant or breastfeeding.
  • You haven't had a live vaccine in the last 4 weeks.
  • You don't have any severe or uncontrolled medical conditions like severe asthma or peanut allergy.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06867393Recruiting· Phase 1
Safety study of HL-003 in healthy volunteers

This trial tests a new medicine called HL-003 in healthy people to see if it is safe and how the body processes it. You may join if you are generally healthy, between 18 and 50 years old, and meet specific health and lifestyle requirements.

Suzhou, Jiangsu
NCT06345703Recruiting· Phase 1
First human trial of NS-136 in healthy volunteers

This study tests a new medication called NS-136 for the first time in people. It aims to see how safe and tolerable the drug is when given to healthy adults. If you are generally healthy, you may be able to take part and help researchers learn about this potential new treatment.

Adelaide, South Australia
NCT07765706Not yet recruiting· Phase 1
Testing an investigational medicine in healthy volunteers

This study tests a new medicine called INS1033 in healthy people to see if it is safe and how the body handles it. It is an early-stage study and does not involve treating any disease.

NCT07662148Recruiting· Phase 1
Testing the safety of BIIB144 in healthy adults

This trial tests a single dose of an experimental drug (BIIB144) in healthy adults to see if it is safe and how the body handles it. You would receive either the drug or a placebo (inactive shot) and be closely monitored.

Las Vegas, Nevada
NCT07448155Recruiting· Phase 1
Testing a new drug in healthy volunteers

This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.

Tempe, Arizona
NCT07708493Not yet recruiting· Phase 1
Study of a new medicine in healthy men with normal or overweight

This study tests how a new medicine (BI 3034701) moves through the body in healthy men who have normal weight or are overweight. It helps find the right dose and understand how the medicine works.

Hear when a new Healthy Subjects trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.